Rhumbline Advisers »

Kinnate Biopharma shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.0k 2.9k 2.37
2023-09-30 $4.1k 2.9k 1.40
2023-06-30 $14k 4.6k 3.03
2023-03-31 $327k 52k 6.24
2022-12-31 $281k 46k 6.10
2022-09-30 $547k 46k 11.95
2022-06-30 $542k 43k 12.62
2022-03-31 $361k 32k 11.25
2021-12-31 $536k 30k 17.71
2021-09-30 $690k 30k 23.02
2021-06-30 $360k 16k 23.29
2021-03-31 $364k 12k 31.12